53 results
8-K
EX-99.1
SYBX
Synlogic Inc
5 Jun 23
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
8:32am
a monotherapy or adjunctive medical treatment.”
“This is exciting news. The PKU community is grateful to Synlogic for their commitment to bringing a new
PRE 14A
1atvxxd5gzf
21 Apr 23
Preliminary proxy
4:00pm
424B5
uti8wq0zjlgp01j
23 Sep 21
Prospectus supplement for primary offering
4:20pm
424B5
nz2nc65wpe4
22 Sep 21
Prospectus supplement for primary offering
4:04pm
8-K
EX-99.1
p163xbhslm d9f7310
17 Jun 21
Synlogic Enters Research Collaboration with Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease
7:35am